ClinicalTrials.gg
Sign In

Pancreatitis, Acute Necrotizing clinical trials

The registry lists 74 studies for Pancreatitis, Acute Necrotizing across more than 10 countries. 19 are recruiting or about to start. 63 of them are mainly about Pancreatitis, Acute Necrotizing (how this is decided). Per ClinicalTrials.gov, last updated 2026-07-10.

Get an email when these change. Save the Pancreatitis, Acute Necrotizing studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
38
Recruiting
12
Status unknown
11
Not yet recruiting
7
Terminated
3
Withdrawn
2

Phase

Phase 4
6
Phase 3
5
Phase 2
3
Early Phase 1
1
Phase 1
1

Where

United States
20
China
17
India
7
France
5
Russian Federation
4
Spain
4

Who runs them

Asian Institute of Gastroenterology, India (4) · AdventHealth (4) · Orlando Health, Inc. (3) · Nantes University Hospital (3) · Chinese University of Hong Kong (2) · Tokyo University (2) · Moscow Regional Research and Clinical Institute (MONIKI) (2) · First People's Hospital of Hangzhou (2)

What is being tested here

Drugs under test in Pancreatitis, Acute Necrotizing studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Pancreatic Enzyme111
Meropenem002
Thymalfasin001
Pentoxifylline001
Streptokinase011
Fluorouracil001

Coming up

2phase 3 studies under way
7studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 7, phase 3 first

Who these studies take

Of the 12 Pancreatitis, Acute Necrotizing studies recruiting now, 9 (75%) set no upper age limit and 3 (25%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 12
AgeWomenMen
100 (0%)0 (0%)
1812 (100%)12 (100%)
3012 (100%)12 (100%)
4012 (100%)12 (100%)
5012 (100%)12 (100%)
6511 (92%)11 (92%)
7510 (83%)10 (83%)
859 (75%)9 (75%)

Across all 74 studies, recruiting or not: 23% stop at 75 or younger and 8% at 65; 11% take children; 0% are for women only and 1% for men only; 4% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Pancreatitis, Acute Necrotizing studies take

Of 20 interventional studies with no phase under Pancreatitis, Acute Necrotizing, half reached primary completion within 29 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase29 mo22–36 · 20 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 74. Browse all 74 → or search them.